Get the Stockscreener App
3.54
0.57%
+0.02
After Hours:
3.64
0.10
+2.82%
NRX Pharmaceuticals Inc stock is currently priced at $3.54, with a 24-hour trading volume of 202.60K.
It has seen a +0.57% increased in the last 24 hours and a -15.31% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $3.59 pivot point. If it approaches the $3.18 support level, significant changes may occur.
Previous Close:
$3.52
Open:
$3.55
24h Volume:
202.60K
Market Cap:
$37.88M
Revenue:
-
Net Income/Loss:
$-30.15M
P/E Ratio:
-6.2105
EPS:
-0.57
Net Cash Flow:
$-21.66M
1W Performance:
+16.45%
1M Performance:
-15.31%
6M Performance:
+1,045%
1Y Performance:
+420.66%
1D Range:
$3.45
$3.79
52W Range:
$0.221
$6.00
NRX Pharmaceuticals Inc Stock (NRXP) Company Profile
Name
NRX Pharmaceuticals Inc
Sector
Industry
Phone
484 254 6134
Address
1201 Orange Street, Suite 600, Wilmington
NRX Pharmaceuticals Inc Stock (NRXP) Latest News
What Is The Ownership Structure Like For NRx Pharmaceuticals, Inc. (NASDAQ:NRXP)? - Yahoo Lifestyle UK
Yahoo Lifestyle UK
Earnings call: NRx Pharmaceuticals outlines strategic growth and clinical advances - Investing.com
Investing.com
Positive Q1 Results Posted After Clinical Trial Delivers Statistically-Significant Data for Bipolar: NRx: - EIN News
EIN News
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q1 2024 Earnings Call Transcript - Insider Monkey
Insider Monkey
NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2024 Financial Results and Provides Business Update - PR Newswire
PR Newswire
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Participate in the EF Hutton Annual Global Conference on May 15, 2024 - PR Newswire
PR Newswire
NRX Pharmaceuticals Inc Stock (NRXP) Financials Data
NRX Pharmaceuticals Inc (NRXP) Net Income 2024
NRXP net income (TTM) was -$30.15 million for the quarter ending December 31, 2023, a +24.16% increase year-over-year.
NRX Pharmaceuticals Inc (NRXP) Cash Flow 2024
NRXP recorded a free cash flow (TTM) of -$21.66 million for the quarter ending December 31, 2023, a +45.53% increase year-over-year.
NRX Pharmaceuticals Inc (NRXP) Earnings per Share 2024
NRXP earnings per share (TTM) was -$4.00 for the quarter ending December 31, 2023, a +34.43% growth year-over-year.
About NRX Pharmaceuticals Inc
NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics for the treatment of bipolar depression in patients with acute suicidal behavior/ideation and sub-acute suicidal ideation and behavior. The company was founded in 2015 and is based in Wilmington, Delaware.
0.77%
1.20%
Cap:
|
Volume (24h):